Wennlund A, Linde B
J Clin Endocrinol Metab. 1984 Aug;59(2):258-62. doi: 10.1210/jcem-59-2-258.
Subcutaneous adipose tissue (AT) blood flow (BF) in the abdomen, thigh, and arm was determined by measuring the local clearance of [133]Xe in patients with untreated hyper- or hypothyroidism (n = 10, n = 7); six patients in each group were reexamined after treatment when they were euthyroid. Abdominal ATBF before treatment was 5.5 +/- 0.8 (SE) ml/min X 100 g AT in the hyperthyroid patients and 1.3 +/- 0.3 ml/min X 100 g AT in those who were hypothyroid. After therapy abdominal ATBF was 60% lower (P less than 0.05) in the hyperthyroid group and 80% higher (P less than 0.05) in the hypothyroid group. Similarly, ATBF in the thigh and arm was significantly reduced and increased, respectively, after treatment in the two groups. The blood glycerol level in the hyperthyroid group was 128 +/- 24 mumol/liter initially and was 50% lower (P less than 0.05) after therapy, whereas in the hypothyroid group blood glycerol levels were similar before (46 +/- 4 mumol/liter) and after therapy. Body fat, expressed as a percentage of body weight, was similar in the two groups before and after treatment. There was a positive correlation (P less than 0.001) between ATBF and serum T3 and T4 levels and an inverse correlation (P less than 0.01) between ATBF and plasma norepinephrine levels. Mean arterial blood pressure was similar in the two groups indicating that the alterations in ATBF were due to changes in vascular resistance. The results of this study suggest that thyroid hormones regulate sc ATBF in man.
通过测量[133]Xe在腹部、大腿和手臂的局部清除率,测定未经治疗的甲状腺功能亢进或减退患者(甲状腺功能亢进组n = 10,甲状腺功能减退组n = 7)皮下脂肪组织(AT)的血流量(BF);每组各6例患者在甲状腺功能恢复正常后接受治疗后再次进行检查。治疗前,甲状腺功能亢进患者腹部ATBF为5.5±0.8(SE)ml/min×100g AT,甲状腺功能减退患者为1.3±0.3 ml/min×100g AT。治疗后,甲状腺功能亢进组腹部ATBF降低60%(P<0.05),甲状腺功能减退组升高80%(P<0.05)。同样,两组治疗后大腿和手臂的ATBF分别显著降低和升高。甲状腺功能亢进组血液甘油水平最初为128±24μmol/L,治疗后降低50%(P<0.05),而甲状腺功能减退组治疗前后血液甘油水平相似(46±4μmol/L)。以体重百分比表示的体脂在两组治疗前后相似。ATBF与血清T3和T4水平呈正相关(P<0.001),与血浆去甲肾上腺素水平呈负相关(P<0.01)。两组平均动脉血压相似,表明ATBF的改变是由于血管阻力变化所致。本研究结果提示,甲状腺激素调节人体皮下ATBF。